CN1935010A - Health food for intensifying body immunological competence and improving memory function, and its preparing method - Google Patents

Health food for intensifying body immunological competence and improving memory function, and its preparing method Download PDF

Info

Publication number
CN1935010A
CN1935010A CNA2006100486782A CN200610048678A CN1935010A CN 1935010 A CN1935010 A CN 1935010A CN A2006100486782 A CNA2006100486782 A CN A2006100486782A CN 200610048678 A CN200610048678 A CN 200610048678A CN 1935010 A CN1935010 A CN 1935010A
Authority
CN
China
Prior art keywords
capsule
health food
american ginseng
memory function
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2006100486782A
Other languages
Chinese (zh)
Other versions
CN1935010B (en
Inventor
闫田芳
丁青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yan Tianfang
Yunnan Dai Medicine Co ltd
Original Assignee
RUILI NATIONAL PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RUILI NATIONAL PHARMACEUTICAL CO Ltd filed Critical RUILI NATIONAL PHARMACEUTICAL CO Ltd
Priority to CN2006100486782A priority Critical patent/CN1935010B/en
Publication of CN1935010A publication Critical patent/CN1935010A/en
Application granted granted Critical
Publication of CN1935010B publication Critical patent/CN1935010B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a health-care food capable of raising immunity of human body and improving memory function. It is made up by using (by weight portion) 2-6 portions of velvet deerhom, 20-60 portions of astragalus root, 2-6 portions of American ginseng, 3-12 portions of Chinese angelica root, 3-12 portions of lyceum berry and 5-18 portions of polygonatum root through a certain preparation method.

Description

A kind of health food and preparation method who strengthens immunity of organisms, improves memory function
Technical field
The present invention relates to the health food technology field, specifically a kind of health food that strengthens immunity of organisms, improves memory function, and its preparation method.
Background technology
At the beginning of this year, national old-age group does first and has externally issued " Chinese population aging prediction of the development trend research report ", points out in the report, and the aging population of China will be followed 21 century all the time.The elderly's health care shoulders heavy responsibilities.
With advancing age, immunity of organisms descends and hypomnesia, is to have two general rules in the mid-aged population.Modern amynologic mechanism discloses, and after 40 years old, body's immunity is along with descending and disorderly, and it has quickened the weak process of body and has reduced resistivity to disease, makes body be subject to the variation of external environment and ill.On the other hand, since the incidence of disease that failure of memory is developed to degenerative brain disorder also be improved largely with the growth at age.Investigation shows in the elderly of one's mid-60s and accounts for 10%, then accounts for 47% in the elderly more than 85 years old, and degenerative brain disorder has become No. four killer of the elderly after heart disease, tumour and cerebral apoplexy.China's investigation demonstration of senile dementia first of being taken the lead and being finished by BJ Union Hospital in 03 year, China is not the low district of sending out of dementia, the incidence of disease and American-European countries close (at present, the people in the population of American-European state more than 60 years old more than 10% suffers from this disease).Treatment for senile dementia is relatively more difficult always, and safe and effective medicine is few, and health food is effectively few.Medicine listings such as Piracetam, Duxil, vinpocetine are arranged at present, senile dementia is had therapeutic action preferably, but side effect is bigger.
The present invention aims to provide a kind of at middle-aged and old immunity degradation, two kinds of symptoms of failure of memory, have concurrently prevention and health care and therapeutic action and health food, and its preparation method.
Summary of the invention
The purpose of this invention is to provide a kind ofly at middle-aged and old immunity degradation, failure of memory has the health food of functions of prevention and health care, and its preparation method.
Health food of the present invention is formulated by following weight portion raw material, pilose antler 2-6, American Ginseng 2-6, Radix Astragali 20-60, Radix Angelicae Sinensis 3-12, fruit of Chinese wolfberry 3-12 and sealwort 5-18.
The best proportioning of above-described health food is: (weight portion): pilose antler 3, American Ginseng 3, the Radix Astragali 30, Radix Angelicae Sinensis 6, the fruit of Chinese wolfberry 6, sealwort 9.
Use above-mentioned raw materials, be equipped with suitable auxiliary material and can be made into capsule, soft capsule, tablet or other oral formulations.
The preparation method of health food of the present invention may further comprise the steps:
1) with the pilose antler crushed after being dried, cross 80~200 mesh sieves, standby;
2) with the American Ginseng crushed after being dried, cross 80~200 mesh sieves, standby;
Perhaps: with American Ginseng 70-80% alcohol extract 2-4 time, each 1-4 hour, extracting liquid filtering, filtrate recycling ethanol concentrates, and drying under reduced pressure was pulverized the 80-200 mesh sieve to dry extract, and was standby;
3) Radix Astragali, Radix Angelicae Sinensis, the fruit of Chinese wolfberry and sealwort were soaked 1-3 hour, added hot reflux 2-4 time, and each 1-4 hour, to filter while hot, filtrate merges, and is evaporated to the medicinal extract that density is 1.2-1.3;
4) by 3) step gained medicinal extract adds the microcrystalline cellulose auxiliary material, mixing continues to be evaporated to dried, pulverizes, with 1) step and 2) step gained powder, 70-90% ethanol system particle, according to a conventional method compacting in flakes, the bag film-coating gets Film coated tablets.
Perhaps: by 3) the thick medicinal extract of step gained adds auxiliary materials such as microcrystalline cellulose, and mixing continues to be evaporated to dried, pulverizes, with 1) and 2) step gained powder, capsule made.
Perhaps: by 3) 80 ℃ of drying under reduced pressure of gained medicinal extract to water content less than 3%, add 1) gained powder and 2) gained American Ginseng extract powder, behind the mixing, add in the soybean oil-beeswax-soybean lecithin mixture of 40-60 ℃ of insulation, the weight ratio of soybean oil, beeswax, soybean lecithin is 5-30: 1: 0.05-0.3, the weight proportion of the medicinal powder behind the mixing and soybean oil-beeswax-soybean lecithin mixture is 1: 0.5-4, stir, ground 10-30 minute, cross 100~200 mesh sieves, 30-60 ℃ is pressed into soft capsule.
The present invention has the health care that strengthens immunity, improves memory, and to hypoimmunity, old degenerative illness such as failure of memory has prevention and supplemental treatment effect.Chinese medicine of the present invention truly has the effect that strengthens immunity and improve memory through clinical confirmation for many years.The inventor has also carried out toxicology test, function assessment test to capsule, and its result also confirms to have and strengthens immunity and improve memory impairments, and safe toxicological test confirmation this product is taken safety for a long time.Because for Chinese medicine preparation (being the integration of drinking and medicinal herbs medicine), action temperature and, side effect is little, can take for a long time, to hypoimmunity and failure of memory, prevention and treatment double action is arranged.
Below be the experimental data of function and effect:
One, capsule function assessment animal test results of the present invention
1. dosage
Everyone (by the 60kg batheroom scale) recommended intake every day is capsule 's content 5g (being equivalent to pilose antler 1g American Ginseng 1g Radix Astragali 10g Radix Angelicae Sinensis 2g fruit of Chinese wolfberry 2g sealwort 3g).Being converted into every day kg body weight dosage is 0.083g/kg.b.w, presses 5 times of human body recommended intakes, 10 times, 25 times designs basic, normal, high 3 dosage groups, i.e. 0.415,0.830,2.075 g/kg.b.w respectively.
2. enhancing immunity function
Test basis: carry out according to " health food check and assessment technique standard " (version in 2003).Experiment is with cleaning level ICR mouse.Get the healthy mice that body weight is 18~22g, random packet, 12 every group experimentize.
2.1 capsule is to mouse immune organ weight's influence
The continuous gastric infusion of each dosage group mouse 10 days, the 10th, 12 day intraperitoneal injection of cyclophosphamide (60mg/kg) respectively except that the normal control group continues to be administered to the 15 day, after the last administration 1 hour, wins and respectively organizes mouse thymus and spleen.Be thymus gland or spleen index with thymus gland or spleen weight (mg) with likening to of body weight (g), experimental result sees Table 1.
Table 1 capsule to mouse immune organ weight's influence (x ± SD, n=12)
Group Dosage (g/kg.b.w) Thymus index Spleen index
Dosage group capsule in high dose group in Normal group Herb Gynostemmae Pentaphylli total glycosides tablet model group (endoxan) the capsule low dose group capsule NS 0.02 - 0.415 0.830 2.075 2.53±0.65 2.33±0.61 1.65±0.69 * 2.02±0.84 2.35±0.88 2.65±0.67 △△ 3.82±0.96 3.64±0.63 2.89±0.62 * 3.03±0.49 3.56±0.94 3.76±0.77
Compare with control group, *P<0.05, *Compare with model group P<0.01, P<0.05, △ △P<0.01 (as follows) is the result show, with model group relatively, the thymus index of the high agent group of capsule mouse is significantly increased (P<0.01), mouse spleen index also has and significantly improves (P<0.05).
2.2 the influence (mtt assay) that capsule transforms ConA inducing mouse SPL
Each dosage treated animal continuous irrigation stomach 30d presses mtt assay, gets spleen, carries out cell and cultivates, handles the back in 570nm wavelength place ELIASA mensuration optical density, the results are shown in Table 2.
The influence that table 2 capsule transforms ConA inducing mouse SPL (x ± SD, n=12)
Group Dosage (g.kg -1.b.w) Add ConA hole and the difference that does not add ConA hole absorbance
Dosage group capsule in high dose group in the normal control group Herb Gynostemmae Pentaphylli total glycosides tablet capsule low dose group capsule NS 0.02 0.415 0.830 2.075 0.007±0.003 0.016±0.005 ** 0.014±0.009 * 0.017±0.006 ** 0.019±0.008 **
2.3 capsule is to the influence of dinitrofluorobenzene (DNFB) inducing mouse delayed allergy
Each dosage treated animal continuous irrigation stomach 30d presses the ear swelling method, the weight of weighing auricle, and capsule sees Table 3 to the influence of DNFB inducing mouse delayed allergy.
Table 3 capsule to the influence of DNFB inducing mouse DTH (x ± SD, n=12)
Group Dosage (g.kg -1.b.w) Auricular concha weightening finish (mg)
Dosage group capsule in high dose group in the normal control group Herb Gynostemmae Pentaphylli total glycosides tablet capsule low dose group capsule NS 0.02 0.415 0.830 2.075 6.5±3.0 11.3±4.1 ** 7.5±1.5 9.6±2.6 ** 11.5±3.6 **
2.4 capsule is to the plain (HC that forms of mice serum HD50 50) influence
Each dosage treated animal continuous irrigation stomach 30d gets blood, and separation of serum is pressed the blood clotting method and observed the hemagglutination degree, and the calculating antibody product sees Table 4.
Table 4 capsule is to mice serum HD50 element (HC 50) form influence (x ± SD, n=12)
Group Dosage (g.kg -1.b.w) HC 50
Dosage group capsule in high dose group in the normal control group Herb Gynostemmae Pentaphylli total glycosides tablet capsule low dose group capsule NS 0.02 0.415 0.830 2.075 46±14 70±32 * 51±25 60±27 * 66±23 *
2.5 the influence that the capsule antagonist generates
Each dosage treated animal continuous irrigation stomach 30d gets blood, with defiber sheep red blood cell (SRBC) immunity 5d, puts to death, and counting splenocyte hemolysis plaque number the results are shown in Table 5
Table 5 capsule to the influence of mouse haemolysis spot number (x ± SD, n=12)
Group Dosage (g.kg -1.b.w) Hemolysis plaque number (10 6Splenocyte)
Dosage group capsule in high dose group in the normal control group Herb Gynostemmae Pentaphylli total glycosides tablet capsule low dose group capsule NS 0.02 0.415 0.830 2.075 136±40 190±46 * 159±51 176±57 202±43 *
2.6 capsule is cleaned up the influence of effect to mouse carbon
Each dosage treated animal continuous irrigation stomach 30d, through intravenous injection dilution prepared Chinese ink, blood is got from intraocular corner of the eyes veniplex in the back, through 0.1mlNaCO 3After the dilution, measure OD value in 600nm.With blood concentration of carbon logarithm the time is mapped.Straight slope K represents with phagocytic index a calibrated back, the results are shown in Table 6.
Table 6 capsule to mouse carbon clean up effect influence (x ± SD, n=12)
Group Dosage (g/kg.b.w) Phagocytic index a
Dosage group capsule in high dose group in the normal control group Herb Gynostemmae Pentaphylli total glycosides tablet capsule low dose group capsule NS 0.02 0.415 0.830 2.075 5.23±0.69 5.19±0.57 5.02±0.91 5.22±0.73 5.08±0.65
2.7 capsule is engulfed each dosage treated animal continuous irrigation stomach 30d of influence (half intracorporal method) of chicken red blood cell to Turnover of Mouse Peritoneal Macrophages, measures macrophage phagocytic function by half intracorporal method, the results are shown in Table 7.
Table 7 capsule to Turnover of Mouse Peritoneal Macrophages engulf the phagocytic rate of chicken red blood cell and the influence of phagocytic index (x ± SD, n=12)
Group Dosage (g/kg.b.w) Phagocytic rate Phagocytic index
Dosage group capsule in high dose group in the normal control group Herb Gynostemmae Pentaphylli total glycosides tablet capsule low dose group capsule NS 0.02 0.415 0.830 2.075 25.4±5.9 26.5±7.5 26.2±4.9 27.1±6.3 28.5±5.7 0.33±0.09 0.34±0.10 0.31±0.07 0.34±0.05 0.36±0.11
2.8 capsule is to the influence (LDH method) of NK cytoactive
Each dosage treated animal continuous irrigation stomach 30d measures the NK cytoactive according to determination of lactate dehydrogenase method (LDH), the results are shown in Table 8.
Table 8 capsule to the influence of NK cytoactive (x ± SD, n=12)
Group Dosage (g/kg.b.w) NK cytoactive (%)
Dosage group capsule in high dose group in the normal control group Herb Gynostemmae Pentaphylli total glycosides tablet capsule low dose group capsule NS 0.02 0.415 0.830 2.075 52.2±16.6 72.5±18.6 * 63.0±22.4 71.9±18.8 * 79.5±26.4 **
According to above-mentioned preparation scheme, the capsule with Chinese traditional medicine composition of the present invention is prepared into confirms that through zoopery mouse immune power is had humidification.
3. improve the effect of memory
3.1 diving tower method
Irritate stomach with 30% ethanol and cause mouse memory reproduction obstacle, observe capsule of the present invention, the results are shown in Table 9 the influence that mouse memory reproduces obstacle.
Table 9 diving tower method is measured capsule reproduces obstacle to mouse memory influence
Group Dosage (g/kg.b.w) Errors number in 5 minutes (n) Diving tower test after 24 hours
Incubation period (n) Mistake percentage (%)
Dosage group capsule in high dose group in the normal control group capsule low dose group capsule NS 0.415 0.830 2.075 5.6±1.3 4.4±2.1 4.3±1.8 * 3.2±1.4 ** 94.5±29.4 123.8±37.1 * 146.1±44.0 ** 153.8±48.7 ** 101.4±39.6 75.6±24.2 * 52.8±24.3 ** 42.5±16.9 **
By Biao Kede, give the basic, normal, high dosage group of medicine of the present invention, the school grade of mouse all presents raising in various degree, and wherein high dose group school grade and memory achievement are compared with model control group and significant difference are all arranged (P<0.001, P<0.05).Point out medicine of the present invention that certain nootropic effect is arranged.
3.2 darkness avoidance test
The results are shown in Table 10.
Table 10 darkness avoidance test is investigated the influence of capsule to mouse memory
Group Dosage (g/kg.b.w) Errors number in 5 minutes (n) Diving tower test after 24 hours
Incubation period (n) Mistake percentage (%)
Dosage group capsule in high dose group in the normal control group capsule low dose group capsule NS 0.415 0.830 2.075 6.8±2.3 5.4±2.0 4.3±1.6 * 3.5±1.4 ** 103.8±35.2 119.4±44.4 134.1±39.5 * 145.3±38.4 ** 102.5±42.7 68.9±28.9 * 55.6±22.1 ** 32.5±14.8 **
3.3 water maze test
The results are shown in Table 11,12.
Table 11 capsule to young rat/mouse labyrinth test effect relatively
Group Dosage (g/kg.b.w) Mistake percentage (%)
Dosage group capsule in high dose group in the normal control group capsule low dose group capsule NS 0.415 0.830 2.075 22.0±4.5 17.4±4.7 16.2±3.4 * 15.3±2.9 *
Table 12 capsule to adult mice maze test effect relatively
Group Dosage (g/kg.b.w) Mistake percentage (%)
Dosage group capsule in high dose group in the normal control group capsule low dose group capsule NS 0.415 0.830 2.075 46.1±16.3 31.6±12.7 * 24.9±13.4 ** 24.3±11.9 **
Zoopery shows that this product is to effect blue or green, that adult mice all has obvious promotion learning and memory function.To sum up, capsule of the present invention has tangible effect to strengthening mouse immune power and improving memory.
Two, safe toxicological test
Test basis: carry out according to " health food check and assessment technique standard " (version in 2003).Experiment is with cleaning level Kunming mouse and cleaning level WISTAR rat.
1. 30 days feeding trials of rat
Assay and evaluation: the pellet that WISTAR kind healthy rat is contained 0.50%, 1.00%, 2.00% capsule every day, dosage is 2.075,4.150,8.300g/kg.b.w, be equivalent to 25,50,100 times of human body recommended amounts, test period totally 30 days, result of the test is:
1) the general physiology sign of rat, behavior, stool and urine, fur etc. are all no abnormal.
2) body weight and food utilization index are normal
3) the blood routine index is normal
4) biochemical indicator is no abnormal
5) each organ coefficient index is normal
6) inspection substantially of organs such as each rat heart, liver,spleen,kidney, small intestine, testis is no abnormal; The liver of control group and high dose group rat, kidney and the pathological observation result of small intestine are basic identical, do not see special pathological change.
2. its mouse oral acute toxicity test (LD 50)
Male, female mice per os LD50>30g/kg.b.w are tried thing capsule of the present invention and are belonged to nontoxic level material.
3. mouse bone marrow cells micronucleus test
1.50 the micronucleus result of~10.0g/kg.b.w dosage is negative, is tried thing capsule of the present invention body cell is not had mutagenesis.
4. mouse sperm deformity test
The spermatic aberration test result of 50~10.0g/kg.b.w dosage is negative, is tried thing capsule of the present invention reproduction cell is not had mutagenesis.
5.Ames test
8-5000 μ g/ ware is tried thing salmonella typhimurium strain TA97, TA98, TA1000, TA102 is carried out the plate infiltration test, no matter when adding and do not add the S9 mixed liquor, each dosage group does not cause that all the back mutation bacterium colony of test strain significantly increases, the Salmonella reversion test result is negative, is tried thing capsule of the present invention and does not have direct or indirect mutagenesis.
Above presentation of results, capsule of the present invention does not have obvious toxic and side effects.
Three, capsule is to strengthening body immunity and improving the clinical efficacy of remembering
1. research object
The young people who (contains 40 years old) below 40 years old more than 18 years, main suit are hypoimmunity, easy catching a cold, every month once or more than, or troubles respiratory tract infection in a year is more than twice.
The elderly more than 40 years old, failure of memory, hypoimmunity or multiple chronic disease.
2. method of administration
The adult, each 5, every day 2 times.
Above research object was a course of treatment with one month all, treated 1-3 the course of treatment.
3, observational technique:
Carry out blood, urine, just routine test and the heart, pulmonary function test, and observe: heating, aversion to cold, sniffle, pharyngeal symptom and whole body situation and the temperature of having a medical check-up, pharyngeal tonsils, tongue picture and resembling, therapeutic evaluation is carried out in variations such as fingerprint respectively.
4, therapeutic evaluation
Observe 319 routine patients altogether, 102 young people wherein, 217 the elderly, its clinical effectiveness sees Table 13:
The clinical observation on the therapeutic effect of table 13 capsule
Project The example number Obviously improve Improve Invalid Total improvement rate (%)
Strengthen immunity and improve memory Young 102 57 48 32 35 13 19 88.2 81.4
Strengthen immunity and improve memory In old 217 years 71 56 31 34 0 12 100 88.3
Side effect of the present invention: outside the period in a medicine small number of patients dry, all do not have any bad reaction, stop using or decrement the dry transference cure.
Clinical research shows, capsule of the present invention to the immunity that strengthens youth and person in middle and old age's human body body, to improve the memory effect obvious, toxic and side effect is little.
The specific embodiment
Embodiment 1
Get parts by weight of raw materials (kilogram): pilose antler 3, American Ginseng 3, the Radix Astragali 20, Radix Angelicae Sinensis 3, the fruit of Chinese wolfberry 3 and sealwort 5, and auxiliary material.
Preparation by the following method:
1) with pilose antler oven dry, pulverize, 100 mesh sieves (80-200 mesh sieve all can), the pilose antler powder;
2) American Ginseng is shone or oven dry, pulverizes, cross 100 mesh sieves (80-200 mesh sieve all can), ginseng powder;
3) Radix Astragali, Radix Angelicae Sinensis, sealwort, the fruit of Chinese wolfberry are added 8 times of water gagings and soaked 1 hour, added hot reflux 2 hours, add 6 times of water gagings again, added hot reflux 2 hours, filter while hot, filtrate merges, and concentrates, and 80 ℃ of drying under reduced pressure are to thick medicinal extract (density is about 1.3);
4) by 3) gained medicinal extract adding microcrystalline cellulose right amount of auxiliary materials (suitable) to viscosity, mixing continues to be evaporated to dried, pulverize, with 1) and 2) the gained powder, with 70-90%7 ethanol system particle, compacting is wrapped film-coating in flakes according to a conventional method, gets Film coated tablets.
Embodiment 2
Get parts by weight of raw materials (kilogram): pilose antler 3, American Ginseng 3, the Radix Astragali 30, Radix Angelicae Sinensis 6, the fruit of Chinese wolfberry 6, sealwort 9, and auxiliary material.
Preparation by the following method:
1) with pilose antler oven dry, pulverize, 100 mesh sieves (80-200 mesh sieve all can), the pilose antler powder;
2) with American Ginseng section, with 8 times of amount 70% alcohol immersion 1 hour, refluxing extraction 2 hours added 6 times of amount 70% alcohol refluxs extraction 2 times, each 1.5 hours again; Filter, filtrate merges, and reclaims ethanol, concentrates, and drying under reduced pressure is to dry extract, pulverizes 100 mesh sieves (80-200 mesh sieve all can), the American Ginseng extract powder;
3) this step is identical with embodiment 1;
4) the microcrystalline cellulose right amount of auxiliary materials being added 3) in the thick medicinal extract such as the step gained Radix Astragali, mixing continues to be evaporated to dry extract, 100 mesh sieves (80-200 mesh sieve all can) were pulverized in cooling, added 1) the pilose antler powder and 2 of step) the American Ginseng extract powder of step, mix, encapsulated, promptly.
Embodiment 3
Get parts by weight of raw materials (kilogram): pilose antler 4, American Ginseng 5, the Radix Astragali 60, Radix Angelicae Sinensis 9, the fruit of Chinese wolfberry 12 and sealwort 18, and auxiliary material.
Make soft capsule:
1) preparation of pilose antler powder, ginseng powder or thick medicinal extract such as the American Ginseng extract powder and the Radix Astragali is with above-mentioned embodiment.
2) 80 ℃ of thick medicinal extract such as the Radix Astragali are continued drying under reduced pressure to water content less than 3%, cooling, pulverized 100 mesh sieves (80-200 mesh sieve all can), add pilose antler powder and ginseng powder or American Ginseng extract powder, behind the mixing, again in the soybean oil-beeswax-soybean lecithin mixture auxiliary material (weight ratio of soybean oil, beeswax, soybean lecithin is 22: 1: 0.2) of 50 ℃ of insulations of weight portion such as adding proportioning, stir, grind 15 minutes (10-30 minute all can), 40 ℃ (30-60 ℃ all can) be pressed into soft capsule, promptly.
Above embodiment and experimental example just illustrate of the present invention, and purpose is to illustrate implementation method of the present invention, and those skilled in the art in conjunction with the various changes that the general knowledge of this area is done, will fall into the protection domain of invention according to enlightenment of the present invention.

Claims (4)

1. health food that strengthens immunity of organisms, improves memory function is characterized in that it is the health food of being made by the following weight parts proportion raw material:
Pilose antler 2-6, American Ginseng 2-6, Radix Astragali 20-60, Radix Angelicae Sinensis 3-12, fruit of Chinese wolfberry 3-12, sealwort 5-18.
2. a kind of health food that strengthens immunity of organisms, improves memory function according to claim 1 is characterized in that optimum weight part proportioning of each raw material is:
Pilose antler 3, American Ginseng 3, the Radix Astragali 30, Radix Angelicae Sinensis 6, the fruit of Chinese wolfberry 6, sealwort 9.
According to claim 1 and 2 described enhancing immunity of organisms, improve the health food of memory function, it is characterized in that described health food is capsule, tablet, soft capsule.
The described enhancing immunity of organisms of claim 1,2 and 3, improve the preparation method of the health food of memory function, it is characterized in that carrying out according to the following steps:
1) with the pilose antler crushed after being dried, cross 80~200 mesh sieves, standby;
2) with the American Ginseng crushed after being dried, cross 80~200 mesh sieves, standby;
Perhaps: with American Ginseng 70-80% alcohol extract 2-4 time, each 1-4 hour, extracting liquid filtering, filtrate recycling ethanol concentrates, and drying under reduced pressure was pulverized the 80-200 mesh sieve to dry extract, and was standby;
3) Radix Astragali, Radix Angelicae Sinensis, the fruit of Chinese wolfberry and sealwort were soaked 1-3 hour, added hot reflux 2-4 time, and each 1-4 hour, to filter while hot, filtrate merges, and is evaporated to the medicinal extract that density is 1.2-1.3;
4) by 3) step gained medicinal extract adds the microcrystalline cellulose auxiliary material, mixing continues to be evaporated to dried, pulverizes, with 1) step and 2) step gained powder, 70-90% ethanol system particle, according to a conventional method compacting in flakes, the bag film-coating gets Film coated tablets.
Perhaps: by 3) the thick medicinal extract of step gained adds auxiliary materials such as microcrystalline cellulose, and mixing continues to be evaporated to dried, pulverizes, with 1) and 2) step gained powder, capsule made.
Perhaps: by 3) 80 ℃ of drying under reduced pressure of gained medicinal extract to water content less than 3%, add 1) gained powder and 2) gained American Ginseng extract powder, behind the mixing, add in the soybean oil-beeswax-soybean lecithin mixture of 40-60 ℃ of insulation, the weight ratio of soybean oil, beeswax, soybean lecithin is 5-30: 1: 0.05-0.3, the weight proportion of the medicinal powder behind the mixing and soybean oil-beeswax-soybean lecithin mixture is 1: 0.5-4, stir, ground 10-30 minute, cross 100~200 mesh sieves, 30-60 ℃ is pressed into soft capsule.
CN2006100486782A 2006-09-15 2006-09-15 Health food for intensifying body immunological competence and improving memory function, and its preparing method Expired - Fee Related CN1935010B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2006100486782A CN1935010B (en) 2006-09-15 2006-09-15 Health food for intensifying body immunological competence and improving memory function, and its preparing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2006100486782A CN1935010B (en) 2006-09-15 2006-09-15 Health food for intensifying body immunological competence and improving memory function, and its preparing method

Publications (2)

Publication Number Publication Date
CN1935010A true CN1935010A (en) 2007-03-28
CN1935010B CN1935010B (en) 2010-06-09

Family

ID=37952894

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006100486782A Expired - Fee Related CN1935010B (en) 2006-09-15 2006-09-15 Health food for intensifying body immunological competence and improving memory function, and its preparing method

Country Status (1)

Country Link
CN (1) CN1935010B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102860495A (en) * 2012-10-09 2013-01-09 三普药业股份有限公司 Anti-anoxia immunity-improving health food and preparation method thereof
CN103006904A (en) * 2012-12-22 2013-04-03 北华大学 Healthcare product with function of strengthening immunity
CN105249461A (en) * 2015-11-10 2016-01-20 山东颐阳生物科技有限公司 American ginseng buccal tablet and making method thereof
CN105533739A (en) * 2015-12-24 2016-05-04 云南千年铁皮石斛开发有限公司 Human body's disease resistance enhancing health-care food and preparation method thereof
CN106701486A (en) * 2017-02-15 2017-05-24 合肥步之道商贸有限公司 Health-maintenance baijiu formula
CN106943517A (en) * 2016-01-06 2017-07-14 吉林大清鹿苑保健科技有限公司 A kind of health products of strengthen immunity and preparation method thereof
CN113186065A (en) * 2021-04-26 2021-07-30 吉林大清鹿苑保健科技有限公司 Health wine for enhancing immunity and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1108804C (en) * 2000-05-19 2003-05-21 牛爱军 Diabetes treating medicine and its prepn. method

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102860495A (en) * 2012-10-09 2013-01-09 三普药业股份有限公司 Anti-anoxia immunity-improving health food and preparation method thereof
CN102860495B (en) * 2012-10-09 2015-06-03 三普药业有限公司 Anti-anoxia immunity-improving health food and preparation method thereof
CN103006904A (en) * 2012-12-22 2013-04-03 北华大学 Healthcare product with function of strengthening immunity
CN105249461A (en) * 2015-11-10 2016-01-20 山东颐阳生物科技有限公司 American ginseng buccal tablet and making method thereof
CN105533739A (en) * 2015-12-24 2016-05-04 云南千年铁皮石斛开发有限公司 Human body's disease resistance enhancing health-care food and preparation method thereof
CN106943517A (en) * 2016-01-06 2017-07-14 吉林大清鹿苑保健科技有限公司 A kind of health products of strengthen immunity and preparation method thereof
CN106701486A (en) * 2017-02-15 2017-05-24 合肥步之道商贸有限公司 Health-maintenance baijiu formula
CN113186065A (en) * 2021-04-26 2021-07-30 吉林大清鹿苑保健科技有限公司 Health wine for enhancing immunity and preparation method thereof

Also Published As

Publication number Publication date
CN1935010B (en) 2010-06-09

Similar Documents

Publication Publication Date Title
CN1935010B (en) Health food for intensifying body immunological competence and improving memory function, and its preparing method
CN101972338B (en) Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof
CN109674958A (en) A kind of Chinese medicine composition and its preparation method and application with anti-trioxypurine
CN101473943B (en) Health-care food for improving memory function and preparation method thereof
CN101243882B (en) Health food with function of reducing blood fat and its preparation
CN106177183A (en) A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori
CN104138526A (en) Granules prepared by combined spicebush roots, dendrobium candidum and ginseng
CN103656410A (en) Traditional Chinese medicine preparation for treating cough and preparation method thereof
CN107095995B (en) A pharmaceutical composition for treating gastritis and gastric ulcer, and its preparation method
CN106177432A (en) A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja, Folium Mori, green tea and Rhizoma Polygonati Odorati
CN107213227A (en) It is a kind of to improve the Chinese medicine compound prescription and its product of constipation
CN104225295B (en) Composition for improving sleep, and preparation method and application thereof
CN105832991A (en) Traditional Chinese medicine composition for treating gastritis
JP2023083223A (en) Composition for preventing, improving or alleviating symptom relating to qi deficiency and/or blood deficiency
CN109223886A (en) Chinese medicine composition and its preparation method and application for invigorating the spleen to arrest diarrhea
CN112755168B (en) Traditional Chinese medicine preparation for treating chronic gastritis caused by helicobacter pylori and preparation method and application thereof
CN104547013A (en) Oral liquid for treating gastric mucosa and liver injury and preparation method of oral liquid
CN101011457A (en) Traditional Chinese medicine composition with immunological enhancement function
CN1911329B (en) Traditional Chinese medicine composition for preventing and/or adjuvant therapy of malignant tumor
CN103536879B (en) A kind of pharmaceutical composition and preparation method for the treatment of diabetes
CN103405722B (en) Chinese herba preparation for preventing and treating infantile cough
CN103520684B (en) Traditional Chinese medicine compound for reducing blood sugar
KR20100104440A (en) Natural tea composition prescribed based on patient's physical constitution
CN107812159A (en) A kind of Chinese medicine composition for treating functional dyspepsia FD and preparation method thereof
CN109966439A (en) A kind of eucommia Bark male flower piece and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: YAN TIANFANG

Free format text: FORMER OWNER: YUNNAN DAI MEDICINE CO., LTD.

Effective date: 20120118

Owner name: YUNNAN DAI MEDICINE CO., LTD.

Effective date: 20120118

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20120118

Address after: 678600 Yunnan Province, Dehong Dai and Jingpo Autonomous Prefecture, Ruili people's Road No. 20 building 2 No. 9

Co-patentee after: YUNNAN DAI MEDICINE Co.,Ltd.

Patentee after: Yan Tianfang

Address before: 678600 Yunnan Province, Ruili Rui Hong Lu middle Ruili National Pharmaceutical Co Ltd

Patentee before: YUNNAN DAI MEDICINE Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100609

CF01 Termination of patent right due to non-payment of annual fee